Latest Insider Transactions at Relay Therapeutics, Inc. (RLAY)
This section provides a real-time view of insider transactions for Relay Therapeutics, Inc. (RLAY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Relay Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Relay Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
295
-0.09%
|
$1,770
$6.26 P/Share
|
|
Jun 10
2024
|
Jami Rubin |
BUY
Exercise of conversion of derivative security
|
Direct |
42,242
+38.58%
|
$211,210
$5.04 P/Share
|
|
Jun 05
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
20,450
-4.52%
|
$143,150
$7.06 P/Share
|
|
Jun 04
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
40,595
-8.23%
|
$243,570
$6.64 P/Share
|
|
Jun 03
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
19,864
-3.87%
|
$119,184
$6.47 P/Share
|
|
Apr 29
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
1,345
-0.26%
|
$8,070
$6.38 P/Share
|
|
Apr 29
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
2,686
-0.51%
|
$16,116
$6.38 P/Share
|
|
Apr 29
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,695
-0.5%
|
$10,170
$6.38 P/Share
|
|
Apr 29
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,623
-0.5%
|
$9,738
$6.38 P/Share
|
|
Mar 27
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
348
-0.11%
|
$2,436
$7.7 P/Share
|
|
Mar 27
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
298
-0.06%
|
$2,086
$7.7 P/Share
|
|
Mar 27
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
765
-0.14%
|
$5,355
$7.7 P/Share
|
|
Mar 27
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
348
-0.1%
|
$2,436
$7.7 P/Share
|
|
Jan 29
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,005
-0.58%
|
$18,045
$9.64 P/Share
|
|
Jan 29
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
1,651
-0.32%
|
$14,859
$9.64 P/Share
|
|
Jan 29
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,929
-0.59%
|
$17,361
$9.64 P/Share
|
|
Jan 29
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
3,178
-0.6%
|
$28,602
$9.64 P/Share
|
|
Jan 16
2024
|
Peter Rahmer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+27.91%
|
-
|
|
Jan 16
2024
|
Sanjiv Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
762,360
+49.95%
|
-
|
|
Jan 16
2024
|
Thomas Catinazzo Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+36.77%
|
-
|
|
Jan 16
2024
|
Brian Adams Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+37.76%
|
-
|
|
Jan 16
2024
|
Donald A Bergstrom President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+35.97%
|
-
|
|
Dec 27
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
244
-0.08%
|
$2,684
$11.51 P/Share
|
|
Dec 27
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
294
-0.2%
|
$3,234
$11.51 P/Share
|
|
Dec 27
2023
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
977
-0.42%
|
$10,747
$11.51 P/Share
|
|
Dec 27
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
294
-0.23%
|
$3,234
$11.51 P/Share
|
|
Oct 30
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
1,354
-0.43%
|
$8,124
$6.03 P/Share
|
|
Oct 30
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,697
-1.16%
|
$10,182
$6.03 P/Share
|
|
Oct 30
2023
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
3,451
-1.45%
|
$20,706
$6.03 P/Share
|
|
Oct 30
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,632
-1.24%
|
$9,792
$6.03 P/Share
|
|
Sep 27
2023
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
648
-0.27%
|
$5,184
$8.38 P/Share
|
|
Sep 27
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
244
-0.08%
|
$1,952
$8.38 P/Share
|
|
Sep 27
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
294
-0.2%
|
$2,352
$8.38 P/Share
|
|
Sep 27
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
294
-0.22%
|
$2,352
$8.38 P/Share
|
|
Jul 28
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,693
-1.15%
|
$18,623
$11.8 P/Share
|
|
Jul 28
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
1,352
-0.42%
|
$14,872
$11.8 P/Share
|
|
Jul 28
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,628
-1.22%
|
$17,908
$11.8 P/Share
|
|
Jul 28
2023
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
2,683
-1.12%
|
$29,513
$11.8 P/Share
|
|
Jun 30
2023
|
Sanjiv Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,662
+50.0%
|
$16,620
$10.68 P/Share
|
|
Jun 30
2023
|
Donald A Bergstrom President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
1,228
+0.51%
|
$12,280
$10.68 P/Share
|
|
Jun 30
2023
|
Peter Rahmer |
BUY
Grant, award, or other acquisition
|
Direct |
1,662
+0.52%
|
$16,620
$10.68 P/Share
|
|
Jun 27
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
244
-0.08%
|
$2,928
$12.12 P/Share
|
|
Jun 27
2023
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
647
-0.27%
|
$7,764
$12.12 P/Share
|
|
Jun 27
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
294
-0.2%
|
$3,528
$12.12 P/Share
|
|
Jun 27
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
294
-0.22%
|
$3,528
$12.12 P/Share
|
|
May 30
2023
|
Peter Rahmer |
BUY
Grant, award, or other acquisition
|
Direct |
161,818
+33.7%
|
-
|
|
May 24
2023
|
Laura Shawver |
SELL
Bona fide gift
|
Direct |
12,099
-23.22%
|
-
|
|
Apr 28
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
863
-0.57%
|
$9,493
$11.16 P/Share
|
|
Apr 28
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
739
-0.47%
|
$8,129
$11.16 P/Share
|
|
Apr 28
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
863
-0.64%
|
$9,493
$11.16 P/Share
|